Study on the Safety of Drug BAY2586116 and How it Works in Patients With Obstructive Sleep Apnea (a Sleep Disorder Caused by the Narrowing and Collapse of the Airway During Sleep) Including the Blood Level of the Drug and Effect of Its Doses and Routes of Administration

Condition:   Sleep Apnea, Obstructive Interventions:   Drug: BAY2586116 (A1);   Drug: Placebo (A2);   Drug: BAY2586116 (B1);   Drug: BAY2586116 (B2);   Drug: BAY2586116 (B3) Sponsor:   Bayer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials